Harbor Perfusion Inc is categorized under Blood Related Health Services in Corpus Christi, TX and active since 1989.
Harbor Perfusion Inc was established in 1989, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 5611101 by the NAICS.
If you are seeking more information, feel free to contact Kevin Corrigan, Owner at the company’s single location by writing to 633 Everhart Road, Corpus Christi, Texas TX 78411 or by phoning (361) 980-1711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Harbor Perfusion Inc |
| Contact Person: | Kevin Corrigan, Owner |
| Address: | 633 Everhart Road, Corpus Christi, Texas 78411 |
| Phone Number: | (361) 980-1711 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1989 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 5611101 |
| Share This Business: |
Harbor Perfusion Inc was started in 1989 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 5611101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Kevin Corrigan, Owner for inquiries that concern Harbor Perfusion Inc by calling the company number (361) 980-1711, as your correspondence is most welcome. Additionally, the physical location of the single location of Harbor Perfusion Inc can be found at the coordinates 27.728725,-97.375427 as well as the street address 633 Everhart Road in Corpus Christi, Texas 78411.
For its online presence, you may visit Harbor Perfusion Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.